🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 359616109
- Market Cap
- Small Cap
- IPO
- 7/18/2019 · $16.00/share
Business: Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases. The Company has developed a proprietary product engine that they employ to systematically identify and validate cellular drug targets that can potentially modulate gene expression to treat the known root cause of genetically defined diseases.
Company Contact
- CEO
- Alex C. Sapir
- CFO
- Esther Rajavelu
- Headquarters
- 26 Landsdowne Street, Cambridge, MA 02139
- Phone
- 617-651-8851
- Investor Relations
- Christina Tartaglia, Stern IR · 212-362-1200 · christina.tartaglia@sternir.com